AstraZeneca inks $6.9-bn breast, gastric cancer therapy deal with Daiichi
AstraZeneca said the transaction won't impact earnings this year but will make a 'significant contribution' by 2023
AstraZeneca said the transaction won't impact earnings this year but will make a 'significant contribution' by 2023 https://ift.tt/2HLWMPa March 28, 2019 at 04:50PM
AstraZeneca said the transaction won't impact earnings this year but will make a 'significant contribution' by 2023 https://ift.tt/2HLWMPa March 28, 2019 at 04:50PM
Comments
Post a Comment